Search

- Aug 9, 2021
- 2 min
Core One Labs moves forward with its clinical development for its psychedelic formulations
These studies will further enhance the Company’s knowledge supporting the use of psychedelics as strong candidates in the treatment ...

- Jun 12, 2021
- 3 min
MYND Life Sciences files patent applications for psilocybin-based drugs for depression
Mynd's process utilizes specific psilocybin analogues that have the ability to positively impact patients with neuropsychiatric disorders.

- Feb 28, 2021
- 1 min
MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive...